Reference
Akyuz F, et al. Inflammatory bowel disease and mycobacteria: How much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?. European Journal of Gastroenterology and Hepatology 31: 777-780, No. 7, Jul 2019. Available from: URL: http://doi.org/10.1097/MEG.0000000000001403 -Turkey
Rights and permissions
About this article
Cite this article
Adalimumab/azathioprine/infliximab. Reactions Weekly 1762, 17 (2019). https://doi.org/10.1007/s40278-019-64756-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-64756-y